Understanding the Development of NCCN Guidelines for High Risk Breast, Ovarian, Pancreatic & Prostate Cancer with Leigha Senter, MS, CGC

• In this presentation, Leigha Senter, a current member of the NCCN Guideline Committee for Genetic/Familial High-Risk Assessment for Breast, Ovarian, Pancreatic, and Prostate cancers will review the process by which these guidelines are written and reviewed. Attendees will learn how evidence is categorized and considered and how varied feedback is considered.

  Level of Instruction: Intermediate

  

  Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.

  

  Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.

Leigha Senter, MS, CGC | Presenter

Cancer Genetic Counselor and Clinical Professor at The Ohio State University’s James Cancer Hospital and Solove Research Institute.

Leigha Senter is a cancer genetic counselor and Clinical Professor at The Ohio State University’s James Cancer Hospital and Solove Research Institute. Currently serving as Interim Director of the Division of Human Genetics, Leigha has more than two decades of research experience in hereditary cancers with a primary focus in BRCA gene-related projects with more than 100 peer reviewed publications. She is currently a member of the NCCN Guideline Committee for Genetic/Familial High-Risk Assessment for Breast, Ovarian, Pancreatic, and Prostate cancers. She’s on the board of trustees for the Association of Cancer Care Centers, an advisory board member for FORCE and past member of the NSGC board of directors.

Rachel Bluebond, MMSc, CGC | Moderator

Oncology Genomic Science Liaison

Rachel Bluebond joined Ambry in 2020 as the Oncology Genomic Science Liaison for the South-Central Region.  In her current role she serves as a clinical liaison for the field team to educate health care providers and key opinion leaders on genetic testing and genomic medicine. Rachel previously worked as a clinical oncology genetic counselor at the University of Texas MD Anderson Cancer Center in Houston, Texas for 7 years and has worked with PWNHealth providing telehealth genetic counseling for 4 years. Rachel has been involved in graduate education at the UT MD Anderson UT Houston School of Biomedical Sciences. She is a member of the National Society of Genetic Counselors and the chair of the Billing Workgroup of the Access and Service Delivery Committee. Rachel received her Master of Medical Science degree in Human Genetics and Genetic Counseling from Emory University and is certified by the American Board of Genetic Counseling.